Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists
US7514077B2 · kind B2 · utility
52Cited by
2References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2007 |
| Grant date | Apr 7, 2009 |
| Priority date | — |
| Expiry date | Jan 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of antagonists to IL-31 are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues. Such antagonists include antibodies and fragments, derivative, or variants thereof. Symptoms such as pain, tingle, sensitization, tickle associated with neuropathies are ameliorated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.